Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Walker

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
CBE Life Sciences Education|June 8, 2021
Teaching Undergraduates to Communicate Science, Cultivate Mentoring Relationships, and Navigate Science CultureDiedra M Wrighting, Jamie Dombach, Mike Walker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor modelsDavid C Blakey, F Russell Westwood, Mike Walker, et al.
Circulation. Heart Failure|October 26, 2018
Neural Networks for Prognostication of Patients With Heart FailureJason Hearn, Heather J Ross, Brigitte Mueller, et al.
European Heart Journal. Digital Health|May 22, 2024
Predicting heart failure outcomes by integrating breath-by-breath measurements from cardiopulmonary exercise testing and clinical data through a deep learning survival neural networkHeather J Ross, Mohammad Peikari, Julie K K Vishram-Nielsen, et al.
International Journal of Hygiene and Environmental Health|November 25, 2025
A comparison of two laboratory methods to measure urinary bisphenol A and triclosan in the Canadian Health Measures SurveyKavita Singh, Tyler Pollock, Subramanian Karthikeyan, et al.
Chemical Research in Toxicology|December 2, 2009
The genotoxicity of mainstream and sidestream marijuana and tobacco smoke condensatesRebecca M Maertens, Paul A White, William Rickert, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 12, 2023
A combined physiologically-based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's diseaseHugo Geerts, Mike Walker, Rachel Rose, et al.
Environmental Research|August 6, 2005
Maternal and umbilical cord blood levels of mercury, lead, cadmium, and essential trace elements in Arctic CanadaJody Butler Walker, Jan Houseman, Laura Seddon, et al.
Molecular Cancer Therapeutics|June 11, 2009
AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenograftsKate F Byth, Andrew Thomas, Gareth Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2008
Imidazole pyrimidine amides as potent, orally bioavailable cyclin-dependent kinase inhibitorsClifford D Jones, David M Andrews, Andrew J Barker, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
CBE Life Sciences Education|June 8, 2021
Teaching Undergraduates to Communicate Science, Cultivate Mentoring Relationships, and Navigate Science CultureDiedra M Wrighting, Jamie Dombach, Mike Walker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor modelsDavid C Blakey, F Russell Westwood, Mike Walker, et al.
Circulation. Heart Failure|October 26, 2018
Neural Networks for Prognostication of Patients With Heart FailureJason Hearn, Heather J Ross, Brigitte Mueller, et al.
European Heart Journal. Digital Health|May 22, 2024
Predicting heart failure outcomes by integrating breath-by-breath measurements from cardiopulmonary exercise testing and clinical data through a deep learning survival neural networkHeather J Ross, Mohammad Peikari, Julie K K Vishram-Nielsen, et al.
International Journal of Hygiene and Environmental Health|November 25, 2025
A comparison of two laboratory methods to measure urinary bisphenol A and triclosan in the Canadian Health Measures SurveyKavita Singh, Tyler Pollock, Subramanian Karthikeyan, et al.
Chemical Research in Toxicology|December 2, 2009
The genotoxicity of mainstream and sidestream marijuana and tobacco smoke condensatesRebecca M Maertens, Paul A White, William Rickert, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 12, 2023
A combined physiologically-based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's diseaseHugo Geerts, Mike Walker, Rachel Rose, et al.
Environmental Research|August 6, 2005
Maternal and umbilical cord blood levels of mercury, lead, cadmium, and essential trace elements in Arctic CanadaJody Butler Walker, Jan Houseman, Laura Seddon, et al.
Molecular Cancer Therapeutics|June 11, 2009
AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenograftsKate F Byth, Andrew Thomas, Gareth Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2008
Imidazole pyrimidine amides as potent, orally bioavailable cyclin-dependent kinase inhibitorsClifford D Jones, David M Andrews, Andrew J Barker, et al.
Pageof 5